Beating the Bio-Terror Threat with Rapid Antimicrobial Susceptibility Testing
Open Access
- 19 July 2021
- journal article
- review article
- Published by MDPI AG in Microorganisms
- Vol. 9 (7), 1535
- https://doi.org/10.3390/microorganisms9071535
Abstract
A bioterror event using an infectious bacterium may lead to catastrophic outcomes involving morbidity and mortality as well as social and psychological stress. Moreover, a bioterror event using an antibiotic resistance engineered bacterial agent may raise additional concerns. Thus, preparedness is essential to preclude and control the dissemination of the bacterial agent as well as to appropriately and promptly treat potentially exposed individuals or patients. Rates of morbidity, death, and social anxiety can be drastically reduced if the rapid delivery of antimicrobial agents for post-exposure prophylaxis and treatment is initiated as soon as possible. Availability of rapid antibiotic susceptibility tests that may provide key recommendations to targeted antibiotic treatment is mandatory, yet, such tests are only at the development stage. In this review, we describe the recently published rapid antibiotic susceptibility tests implemented on bioterror bacterial agents and discuss their assimilation in clinical and environmental samples.Keywords
This publication has 110 references indexed in Scilit:
- Evaluation of the FilmArray ® system for detection of Bacillus anthracis, Francisella tularensis and Yersinia pestisJournal of Applied Microbiology, 2013
- Standardized broth microdilution antimicrobial susceptibility testing of Francisella tularensis subsp. holarctica strains from Europe and rare Francisella speciesJournal of Antimicrobial Chemotherapy, 2012
- Modeling Inhalational Tularemia: Deliberate Release and Public Health ResponseBiosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science, 2011
- Use of Acid Treatment and a Selective Medium To Enhance the Recovery of Francisella tularensis from WaterApplied and Environmental Microbiology, 2011
- Use of an In Vitro Pharmacodynamic Model To Derive a Moxifloxacin Regimen That Optimizes Kill of Yersinia pestis and Prevents Emergence of ResistanceAntimicrobial Agents and Chemotherapy, 2011
- In Vitro Susceptibility of Isolates of Francisella tularensis Types A and B from North AmericaAntimicrobial Agents and Chemotherapy, 2008
- Impact of Resistance Selection and Mutant Growth Fitness on the Relative Efficacies of Streptomycin and Levofloxacin for Plague TherapyAntimicrobial Agents and Chemotherapy, 2007
- Francisella tularensis:Taxonomy, Genetics, and Immunopathogenesis of a Potential Agent of BiowarfareAnnual Review of Microbiology, 2006
- Resistance of Yersinia pestis to Antimicrobial AgentsAntimicrobial Agents and Chemotherapy, 2006
- Synthesis of a selective agar medium for Yersinia enterocoliticaCanadian Journal of Microbiology, 1979